Member Info for a-2-b

P140 can be applied to a lot of different diseases really due to it acting on the same pathways within the body. Could be a great multi-treatment for many diseases, but one thing at a time.

http://www.immupharma.co.uk/wp-content/uploads/2017/08/Autophagy-Muller-et-al.-Autoimm-Rev-2017.pdf

P140 even could prevent/help with cancer as cell autophagy can cause it.

In relation to p140 it acts on pathways similar to most autoimmune diseases HIV included. Wouldn't be surprised if it helps with cancer to be honest as it acts on CD4 and doesn't effect the immune system allowing patients to fight off other potential infections while receiving the treatment.

Only 550k before NT can get 500k at a slightly lower premium

Nice

I'd say nothing below £1.44 due to the last fundraiser.

Worth hell of a lot more as the other peptides are very promising and some addressing diseases where no treatments exist at all!

Ask close to 0.4 now!

Must be barely any left I have 1.62% of shares now, as will a lot of others. I'm guessing there will be about 10% or less left out of total volume. Sure we'll see buys coming in the rest of month leading up to report and long awaited acquisition news.

It's popped to .385 now up to 500k shares anything over it starts getting silly over .39+ then NT @ 600k

one day they file on nex the next elsewhere

Just filled all at 0.38

They aren't responsive to e-mails. News flow is meagre as well as exposure, sometimes I think they forget they are a main market listing and should start acting like it. Hopefully news flow will pick up and they'll have plenty to shout about soon. Messaged them about the site being half baked dead links and half updated pages needs improvement not hard either really.

Not long till half year report maybe even news on acquisition can only get up to a block of 500k shares @ .38 anything slightly more and it goes to over .39+ then NT.

I think there is such a low volume of shares left now, I pretty much plugged up the last sell as it was letting me buy descent amounts to compensate for it at the time. Now it's probably going back to small amounts again, unless you place a order but could pop up anywhere judging by the price paid today. The spread has doubled now too.

https://www.bloombergquint.com/onweb/2018/07/11/removing-the-hidden-obstacle-holding-back-new-cancer-therapies

CAR-T is expensive and toxic now apparently. N6L could be a good acquisition we know it can bind to chemodrugs and DNA as well as targeting small difficult to treat tumours.

https://www.medicalnewstoday.com/articles/322410.php

Can't get a price for any amount today. I'd say it's more than definitely gonna happen being on the main market they'd have better exposure in general and to more cash resources than anywhere else. Gla this is gonna be great.

Very complementary to AAAP, maybe even a rto of AfriAG I feel something will be on the cards anyway personally.

The lack of action today at afriag tells me this is on nobodies radar really.

Only way is up now won't be seeing 6.5 again

He also talks about going through 'certain process' at the end I wonder if that's a reference to the legal license. This all speculation of course, but makes sense.